Canopy Growth Corp (CGC)
9.03
-0.45
(-4.75%)
USD |
NASDAQ |
May 08, 16:00
9.17
+0.14
(+1.55%)
After-Hours: 20:00
Canopy Growth Total Return Level: 9.03 for May 8, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 08, 2024 | 9.03 |
May 07, 2024 | 9.48 |
May 06, 2024 | 9.72 |
May 03, 2024 | 10.24 |
May 02, 2024 | 10.34 |
May 01, 2024 | 11.44 |
April 30, 2024 | 14.88 |
April 29, 2024 | 8.32 |
April 26, 2024 | 8.91 |
April 25, 2024 | 8.70 |
April 24, 2024 | 8.97 |
April 23, 2024 | 9.03 |
April 22, 2024 | 7.85 |
April 19, 2024 | 7.93 |
April 18, 2024 | 7.83 |
April 17, 2024 | 6.49 |
April 16, 2024 | 6.70 |
April 15, 2024 | 6.98 |
April 12, 2024 | 7.80 |
April 11, 2024 | 8.15 |
April 10, 2024 | 9.12 |
April 09, 2024 | 9.16 |
April 08, 2024 | 10.13 |
April 05, 2024 | 10.18 |
April 04, 2024 | 9.78 |
Date | Value |
---|---|
April 03, 2024 | 10.89 |
April 02, 2024 | 8.35 |
April 01, 2024 | 7.53 |
March 28, 2024 | 8.63 |
March 27, 2024 | 9.55 |
March 26, 2024 | 7.23 |
March 25, 2024 | 6.20 |
March 22, 2024 | 7.69 |
March 21, 2024 | 4.56 |
March 20, 2024 | 4.54 |
March 19, 2024 | 3.83 |
March 18, 2024 | 3.71 |
March 15, 2024 | 3.08 |
March 14, 2024 | 2.77 |
March 13, 2024 | 2.96 |
March 12, 2024 | 2.92 |
March 11, 2024 | 3.01 |
March 08, 2024 | 3.05 |
March 07, 2024 | 2.97 |
March 06, 2024 | 2.91 |
March 05, 2024 | 2.89 |
March 04, 2024 | 3.02 |
March 01, 2024 | 3.21 |
February 29, 2024 | 3.29 |
February 28, 2024 | 3.36 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
2.77
Minimum
Mar 14 2024
521.70
Maximum
Feb 10 2021
132.55
Average
126.30
Median
Oct 29 2021
Total Return Level Benchmarks
Tilray Brands Inc | 1.95 |
Clever Leaves Holdings Inc | 2.63 |
Flora Growth Corp | 1.52 |
Acasti Pharma Inc | 2.89 |
Aurinia Pharmaceuticals Inc | 5.15 |